Month: September 2020

VANCOUVER, British Columbia, Sept. 24, 2020 (GLOBE NEWSWIRE) — Uniserve Communications Corporation (“Uniserve”) a provider of IT solutions and services to business and residential customers in Canada wishes to announce its annual fiscal 2020 financial results.   Revenues for fiscal 2020 were $12,359K as compared to $12,251K for the prior fiscal year, an increase of 1%. The annual fiscal 2020 Operating loss was $1,632K compared to an operating loss of $2,507K for the prior fiscal year. Net loss for fiscal 2020 was $3,496K as compared to $3,009K for the prior fiscal year. Included in the current year Net Loss were impairment charges totaling $1,772K. During the year Uniserve focused on reducing operational costs and improving processes across the organization.About UniserveUniserve Communications Corporation is a 2018 TSX Venture...

ATLANTA, GA, Sept. 24, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the pricing of its underwritten public offering of 2,560,000 units at a price to the public of $5.00 per unit. Each unit issued in the offering consists of one share of common stock (or pre-funded warrant to purchase common stock in lieu thereof) and one warrant to purchase one share of common stock at an exercise price of $5.00. The common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants are immediately separable and will be issued separately. The common stock and warrants are expected to begin trading on the Nasdaq Capital Market,...

SUWON, Republic of Korea, Sept. 24, 2020 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to evaluate the efficacy of OLX10010 as an adjunct therapy to reduce the recurrence of hypertrophic scars after scar revision surgery.Hypertrophic scars are the result of an overgrowth of collagen in the dermis (the skin’s next layer) that may cause functional impairment and cosmetic disfigurement. Hypertrophic scarring occurs in 40% to 70% of patients following surgery. Currently, there is no FDA-approved drugs and few treatments supported by well-designed prospective studies.The purpose of this prospective, randomized, double-blind, intra-subject, placebo-controlled...

WILMINGTON, Del., Sept. 24, 2020 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Prelude, before deducting underwriting commissions and offering expenses, are expected to be approximately $158.2 million. All of the shares of common stock are being offered by Prelude Therapeutics. In addition, Prelude Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,248,750 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.The shares are expected to begin trading on the Nasdaq Global Select Market on September 25, 2020...

MONACO, Sept. 24, 2020 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today an update on financing facilities, which are expected to increase liquidity by approximately $82.0 Million. The Company has finalized commitments from three financial institutions for the sale and leaseback of eight MR product tankers that were previously mentioned and has received a new commitment for a scrubber financing facility.Sale and Leaseback FacilitiesTwo of the eight vessels have already been delivered to their buyer, and the remaining six vessels are expected to be delivered to their buyers in the fourth quarter of 2020.Upon completion of all the transactions for the eight vessels and the repayment of their existing debt, the Company expects to have raised approximately $70 million of liquidity...

REDWOOD CITY, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines to treat chronic vision-threatening diseases of the retina and optic nerve, today announced the pricing of its upsized initial public offering of 5,625,000 shares of common stock at a public offering price of $16.00 per share. All of the shares are being offered by Graybug. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Graybug, are expected to be $90.0 million. In addition, Graybug has granted the underwriters a 30-day option to purchase up to an additional 843,750 shares of common stock at the initial public offering price, less underwriting discounts and commissions....

CRANBURY, N.J., Sept. 24, 2020 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, today announced the pricing of its initial public offering of 11,765,000 shares of common stock at a public offering price of $18.00 per share. PMV Pharma’s common stock is expected to begin trading on the Nasdaq Global Select Market on September 25, 2020 under the ticker symbol “PMVP.”The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by PMV Pharma, are expected to be approximately $211.8 million. The offering is expected to close on September 29, 2020, subject to the satisfaction of customary closing conditions. In addition, PMV Pharma has...

Maha Energy AB (publ)Strandvägen 5ASE-114 51 Stockholmwww.mahaenergy.caPress ReleaseStockholmSeptember 25, 2020Maha Energy AB (publ) to be awarded new exploration block onshore Oman (“Block 70” or “Mafraq”)Maha Energy AB (“Maha” or the “Company”) is pleased to announce that it will be awarded a new exploration block by the Ministry of Energy and Minerals of the Sultanate of Oman. Block 70 is an onshore block that includes the shallow undeveloped Mafraq heavy oil field.  The Block is located in the middle of the prolific and oil producing Ghaba Salt Basin in the central part of Oman.  Maha will (through a wholly owned subsidiary) be the operator of the Block and hold a 100% working interest. The entry into Oman marks a milestone for the Company’s diversification strategy. The Block agreement is scheduled to be signed...

TORONTO, Sept. 24, 2020 (GLOBE NEWSWIRE) — (TSX Venture:FTI) FTI Foodtech International Inc. (“FTI”) announces that it is adding two products – four-layer face masks and antiseptic wipes – to its product lineup of Personal Protective Equipment (PPE) available through its online store at fti.ppebrand.com. Interest in this product category continues as the prevalence of COVID-19 continues.  The four-layer, sterilized, disposable, non-medical-use face masks have a bacteria, odour and dust filter of non-woven material. The product is approved by Health Canada and is manufactured in Vietnam.The Fusion brand antiseptic wipes are 75% ethyl alcohol based and effective in destroying harmful germs and bacteria. Used for effective antiseptic cleansing, the product is a medicated (skin) cleanser and is Health Canada approved.FTI...

TORONTO, 24 sept. 2020 (GLOBE NEWSWIRE) — FTI Foodtech International Inc. (TSXV : FTI) (« FTI » ou la « Société ») est heureuse d’annoncer qu’elle ajoute deux nouveaux produits à sa gamme d’équipements de protection individuelle (ÉPI), des masques à quatre couches ainsi que des lingettes antiseptiques, qui seront disponibles sur sa boutique en ligne au fti.ppebrand.com. L’intérêt pour cette gamme de produits ne cesse de croître alors que la pandémie de COVID-19 se poursuit.  Les masques faciaux à quatre couches, à usage non médical, stérilisés et jetables sont dotés d’un filtre antibactérien, anti-odeur et anti-poussière et sont fabriqués à partir de matériaux non tissés. Ces masques sont approuvés par Santé Canada et sont fabriqués au Vietnam.  Les lingettes antiseptiques de la marque Fusion sont à base d’alcool éthylique 75 % et...